Riassunto
I tumori della testa e del collo rappresentano circa il 5–10% delle neoplasie pediatriche; gli organi più frequentemente colpiti sono, in ordine di frequenza, la tiroide, l’orbita, il rinofaringe, le tonsille e i seni paranasali [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliografia
Chadha NK, Forte V (20i9) Pediatric head and neck malignancies. Curr Opin Otolaryngol Head Neck Surg 17:471–476
Gosepath J, Spix C, Talebloo B et al (2007) Incidence of childhood cancer of the head and neck in Germany. Ann Oncol 18:1716–1721
Wexler LH, Crist WM, Helman LJ et al (2002) Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology, 4th edn. Lippincott Williams & Wilkins, Philadelphia pp 939–971
Meazza C, Ferrari A, Casanova M et al (2006) Rhabdomyosarcoma of the head and neck region: experience at the pediatric unit of the Istituto Nazionale Tumori, Milan. J Otolaryngol 35:53–59
Stevens M (2002) Rhabdomyosarcoma. In: Pinkerton R, Philip T, Fervers B (eds) Evidence-based Paediatric Oncology, BMJ Books, London, pp 3–27
Parham DM (2001) Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 14:506–514
Meazza C, Ferrari A, Casanova M et al (2005) Evolving treatment strategies for parameningeal rhabdomyosarcoma: the experience of the Istituto Nazionale Tumori of Milan. Head Neck 27:49–57
Oberlin O, Rey A, Lyden E et al (2008) Prognostic factor in metastatic rhabomyosarcoma: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 26:2384–2389
Ferrari A, Casanova M (2005) Current chemo therapeutic strategies for rhabdomyosarcoma. Expert Rev Anticancer Ther 5:283–294
Crist WM, Anderson JR, Meza JL et al (2001) Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19:3091–3102
Koscielniak E, Harms D, Henze G et al (1999) Results of treatment for soft tissue sarcoma in childhood and adolscence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 17:3706–3719
Stevens MC, Rey A, Bouvet N et al (2005) Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology—SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 23:2618–2628
Raney RB, Meza J, Anderson JR et al (2002) Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through-IV, 1978-1997. Med Pediatr Oncol 38:22–32
Schuck A, Mattke AC, Schmidt B et al (2004) Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary? J Clin Oncol 22:143–149
Michalski JM, Meza J, Breneman JC et al (2004) Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. Int J Radiat Oncol Biol Phys 59:1027–1038
Wolden SL, Anderson JR, Crist WM et al (1999) Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol 17:3468–2475
Viswanathan AN, Grier HE, Litman HJ et al (2004) Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy. Int J Radiat Oncol Biol Phys 58:1208–1214
Stevens MC (2005) Treatment for childhood rhabdomyosarcoma: the cost of cure. Lancet Oncol 6:77–84
Oberlin O, Rey A, Anderson J et al (2001) Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment — results of an international workshop. J Clin Oncol 19:197–204
Bisogno G, Ferrari A, Bergeron C et al (2005) The IVADo regimen, a pilot study with ifosfamide, vincristine, actinomycin aid doxorubicin in children with metastatic soft tissue sarcoma. A pilot study by the European pediatric Soft Tissue Sarcoma Study Group. Cancer 103:1719–1724
Pappo AS, Lyden E, Breneman J et al (2001) Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an Intergroup Rhabdomyosarcoma Study. J Clin Oncol 19:213–219
Walterhouse DO, Lyden ER, Breitfeld PP et al (2004) Efficacy of topotecan and cyclophosphamide given as a phase II window in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. J Clin Oncol 22:1–7
Klingebiel T, Boos J, Beske F et al (2008) Treatment of children with metstatic soft tissue sacoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatr Blood Cancer 50:739–745
Casanova M, Ferrari A, Bisogno G et al (2004) Vinorelbine and low-dose cyclophodphamide in the treatment of pediatric sarcomas. Pilot study for the upcoming European Rhabdomyosarcoma Protocol. Cancer 101:1664–1671
Paulino AC, Simon JH, Zhen W, Wen BC (2000) Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Phys 48:1489–1495
Massimino M, Collini P, Fagundes Leite S et al (2006) Conservative surgical approach for thyroid and lymph-node involvement in papillary thyroid carcinoma of childhood and adolescence. Pediatr Blood Cancer 46:307–13
Collini P, Mattavelli F, Pellegrinelli A et al (2006) Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behavior and prognosis: a clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am J Surg Pathol 30:1420–1426
Kumagai A, Namba H, Saenko VA et al (2004) Low frequency of BRAF1796A mutations in childhood thyroid carcinomas. J Clin Endocrinol Metab 89:4280–4284
Sandlund JT, Downing JR, Crist WM (1996) Non-Hodgkin’s lymphoma in childhood. N Engl J Med 334:1238–1248
Pfeiffer J, Kayser G, Riddder GJ (2009) Sonography-assisted cutting needle biopsy in the head and neck for the diagnosis of lymphoma: can it replace lymph node extirpation? Laryngoscope 119:689–695
Gross TG, Termuhlen AM (2007) Pediatric non-Hodgkin’s lymphoma. Curr Oncol Rep 9:459–465
Olson MR, Donaldson SS (2008) Treatment of pediatric Hodgkin lymphoma. Curr Treat Options Oncol 9:81–94
Casanova M, Ferrari A, Gandola L et al (2001) Undifferentiated nasopharyngeal carcinoma in children and adolescents: Comparison between staging systems. Ann of Oncol 12:1157–1162
Rodriguez-Galindo C, Wofford M, Castelberry RP et al (2005) Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, andleucovorin for pediatric nasopharyngeal carcinoma. Cancer 103:850–857
Sultan I, Casanova, M, Ferrari A et al (2010) Differential features of nasopharyngeal carcinoma in children and adults: A SEER study. Pediatr Blood Cancer 55:279–284
Downing NL, Wolden S, Wong P et al (2009) Comparison of treatment results between adult and juvenile nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 75:1064–1070
Mertens R, Granzen B, Lassay S et al (2005) Treatment of nasopharyngeal carcinoma carcinoma in children and adolescents: definitive results of amulticenter study (NPC-91-GPOH). Cancer 104:1083–1089
Guzzo M, Ferrari A, Marcon I et al (2006) Salivary gland neoplasms in pediatric age: the experience of the Istituto Nazionale Tumori of Milan. Pediatr Blood Cancer 47:806–810
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Italia
About this chapter
Cite this chapter
Casanova, M. (2011). Tumori in età pediatrica. In: Tumori della testa e del collo. Springer, Milano. https://doi.org/10.1007/978-88-470-1806-8_20
Download citation
DOI: https://doi.org/10.1007/978-88-470-1806-8_20
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1805-1
Online ISBN: 978-88-470-1806-8
eBook Packages: MedicineMedicine (R0)